全文获取类型
收费全文 | 1425篇 |
免费 | 100篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 58篇 |
妇产科学 | 10篇 |
基础医学 | 140篇 |
口腔科学 | 21篇 |
临床医学 | 113篇 |
内科学 | 323篇 |
皮肤病学 | 45篇 |
神经病学 | 201篇 |
特种医学 | 63篇 |
外国民族医学 | 10篇 |
外科学 | 246篇 |
综合类 | 8篇 |
预防医学 | 151篇 |
眼科学 | 9篇 |
药学 | 67篇 |
中国医学 | 1篇 |
肿瘤学 | 56篇 |
出版年
2023年 | 10篇 |
2022年 | 17篇 |
2021年 | 39篇 |
2020年 | 26篇 |
2019年 | 54篇 |
2018年 | 72篇 |
2017年 | 33篇 |
2016年 | 35篇 |
2015年 | 36篇 |
2014年 | 48篇 |
2013年 | 80篇 |
2012年 | 110篇 |
2011年 | 111篇 |
2010年 | 52篇 |
2009年 | 70篇 |
2008年 | 84篇 |
2007年 | 71篇 |
2006年 | 89篇 |
2005年 | 71篇 |
2004年 | 53篇 |
2003年 | 56篇 |
2002年 | 52篇 |
2001年 | 27篇 |
2000年 | 16篇 |
1999年 | 21篇 |
1998年 | 8篇 |
1997年 | 9篇 |
1996年 | 12篇 |
1995年 | 7篇 |
1994年 | 7篇 |
1993年 | 5篇 |
1992年 | 17篇 |
1991年 | 14篇 |
1990年 | 17篇 |
1989年 | 7篇 |
1988年 | 4篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 13篇 |
1984年 | 3篇 |
1983年 | 6篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1970年 | 7篇 |
1969年 | 2篇 |
排序方式: 共有1527条查询结果,搜索用时 15 毫秒
31.
32.
Knobel H Escobar I Polo R Ortega L Martín-Conde MT Casado JL Codina C Fernández J Galindo MJ Ibarra O Llinas M Miralles C Riera M Fumaz CR Segador A Segura F Chamorro L 《Enfermedades infecciosas y microbiología clínica》2005,23(4):221-231
Since the early days of antiretroviral therapy, adherence has emerged as the milestone of success; in fact, it is the most potent predictor of effectiveness. The main factors related to adherence include the complexity of the therapeutic regimen, adverse effects, psychological problems, alcoholism and active addiction to drugs, lack of social and family support and the patient's beliefs and attitudes about the treatment. Adherence monitoring should be part of the HIV patient's regular care, and should be done with feasible, easily applied methods adapted to the different clinical settings. The minimally acceptable measures should include use of a validated questionnaire, together with data from the Pharmacy Department's drug dispensation registry. All patients that begin HAART or undergo a change of treatment should participate in a treatment education program imparted by health professionals with knowledge and experience in the management of patients with HIV infection. The health team (doctors, pharmacists and nursing professionals) should offer maximum availability to solve the doubts and problems that may occur during treatment. When sub-optimal adherence is detected, intervention strategies based on psychological therapy, educational efforts and personal advice should be attempted, in order to adapt the treatment scheme to the patient's habits and provide solutions to the problem of non-compliance. In certain situations, co-morbid conditions will also require attention. Treatment adherence, being a multidimensional problem, needs a multidisciplinary team approach. The choice of therapy, only one aspect of the multidimensional problem of adherence, must be a careful and individualized decision; however, simpler regimens with regard to the number of pills and daily dose are desirable. 相似文献
33.
34.
Eduard Gallardo Arunkanth Ankala Yaiza Núñez‐Álvarez Madhuri Hegde Jordi Diaz‐Manera Noemí De Luna Ana Pastoret Mònica Suelves Isabel Illa 《Human mutation》2014,35(8):990-997
Dysferlinopathies are autosomal recessive inherited muscular dystrophies caused by mutations in the gene DYSF. Dysferlin is primarily expressed in skeletal muscle, cardiac muscle, and peripheral blood monocytes. Expression in skeletal muscle and monocytes strongly correlates in healthy and disease states. We evaluated the efficiency of the monocyte assay to detect carriers and to determine the carrier frequency of dysferlinopathies in the general population. We enrolled 149 healthy volunteers and collected peripheral blood samples for protein analysis. While 18 of these individuals with protein levels in the range of 40%–64% were predicted to be carriers by the monocyte assay, subsequent DYSF sequencing analysis in 14 of 18 detected missense variants in only four. Analysis of DNA methylation patterns at the DYSF locus showed no changes in methylation levels at CpG islands and shores between samples. Our results suggest that: (1) dysferlin expression can also be regulated by factors outside of the dysferlin gene, but not related to DNA methylation; (2) carrier frequency and therefore the number of affected individuals could be higher than previously estimated; and (3) although reliable for evaluating dysferlinopathies, the monocyte assay cannot be used to determine the carrier status; for this, a molecular analysis of DYSF must be performed. 相似文献
35.
36.
Laia Garcia-Bellmunt Oriol Sibila Ingrid Solanes Ferran Sanchez-Reus Vicente Plaza 《Archivos de bronconeumología》2012
Introduction
Pulmonary nocardiosis (PN) is a severe infection with a high morbidity and mortality that mainly affects immunocompromised patients. In recent years, an increase in PN cases has been detected among patients with chronic obstructive pulmonary disease (COPD). The factors that are associated with its presence and determine its prognosis remain unknown.Methods
Retrospective study of COPD patients diagnosed with PN over the period from 1997-2009 at the Hospital de la Santa Creu i Sant Pau, in Barcelona (Spain). Demographic, clinical, microbiological and evolution data were evaluated in all casesResults
Thirty patients were identified with PN and COPD. Mean age (standard deviation) was 76 (7) years and the mean FEV1 was 40 (14)%. Chronic respiratory failure was observed in 56,7% patients and 51,7% had received systemic corticosteroid therapy previous to the PN diagnosis. The most common symptoms were cough and dyspnea (90%). Alveolar infiltrates were observed in 60% of the cases. The most frequently isolated Nocardia species was N. cyriacigeorgica (68%). The one-month mortality rate was 17%, while the one-year mortality rate was 33%. The factors associated with mortality within the first year included previous systemic corticosteroid treatment, less than three months of specific antibiotic therapy and active associated neoplasm.Conclusions
PN affects patients with moderate-severe COPD and has high short- and mid-term mortality rates. Previous corticosteroid treatment, specific antibiotic therapy for less than 3 months and active neoplasia were factors associated with mortality. 相似文献37.
38.
39.
40.